Christopher Durant Turner

Insider Reports History

Location
One Broadway, 14 Th Floor, Cambridge, MA
Signature
/s/ Nathan McConarty, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Durant Turner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nuvalent, Inc. Chief Medical Officer Class A Common Stock 62.5K $5.04M $80.54 Jan 6, 2025 Direct
Nuvalent, Inc. Chief Medical Officer Stock Option (Right to Buy) 37.5K Jan 6, 2025 Direct

Insider Reports Filed by Christopher Durant Turner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NUVL Nuvalent, Inc. Jan 6, 2025 5 -$320K 4 Jan 8, 2025 Chief Medical Officer
NUVL Nuvalent, Inc. Jan 5, 2024 2 $0 4 Jan 9, 2024 Chief Medical Officer
NUVL Nuvalent, Inc. Oct 4, 2023 8 -$377K 4 Oct 6, 2023 Chief Medical Officer
NUVL Nuvalent, Inc. Jul 26, 2023 6 -$207K 4 Jul 28, 2023 Chief Medical Officer
NUVL Nuvalent, Inc. Jul 20, 2023 6 -$12K 4 Jul 24, 2023 Chief Medical Officer
NUVL Nuvalent, Inc. Jun 5, 2023 3 -$389K 4 Jun 7, 2023 Chief Medical Officer
NUVL Nuvalent, Inc. Jan 6, 2023 1 $0 4 Jan 6, 2023 Chief Medical Officer
NUVL Nuvalent, Inc. May 17, 2022 2 $100K 4 May 19, 2022 Chief Medical Officer
NUVL Nuvalent, Inc. Jan 4, 2022 1 $0 4 Jan 5, 2022 Chief Medical Officer
NUVL Nuvalent, Inc. Jul 28, 2021 0 $0 3 Jul 28, 2021 Chief Medical Officer